MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2017 International Congress

    [11C]PK11195 PET Imaging Reveals Neuroinflammation in Dementia with Lewy Bodies: NIMROD Study

    A. Surendranathan, L. Su, L. Passamonti, Y. Hong, W. Bevan-Jones, R. Arnold, P. Vázquez Rodríguez, E. Mak, T. Fryer, F. Aigbirhio, J. Rowe, J. O'Brien (Cambridge, United Kingdom)

    Objective: To determine if subjects with dementia with Lewy bodies(DLB) have increased microglial activation in vivo compared to matched healthy controls as assessed using PET…
  • 2017 International Congress

    Metabolic changes following transcranial magnetic resonance-guided focused ultrasound subthalamotomy

    R. Rodriguez-Rojas, R. Martinez-Fernandez, J. Pineda-Pardo, C. Sanchez-Catasus, M. del Alamo, J. Obeso (Mostoles, Spain)

    Objective: As part of a pioneer trial to investigate the use of transcranial magnetic resonance-guided focused ultrasound subthalamotomy (MRgFUS-STN) in Parkinson's disease (PD), this study addresses…
  • 2017 International Congress

    Correlation analysis between dopamine release in striatal sub-regions and motor impairment in Parkinson’s disease subjects

    I. Klyuzhin, M. Sacheli, N. Vafai, E. Shahinfard, B. Lakhani, J. Neva, J. Fu, J. McKenzie, N. Neilson, K. Dinelle, L. Boyd, A. Stoessl, V. Sossi (Vancouver, BC, Canada)

    Objective: To investigate correlations between the sub-regional dopamine release (DR) in the striatum of Parkinson’s disease (PD) subjects and sub-components of motor performance evaluated according…
  • 2017 International Congress

    FDG PET studies in the differential diagnose of atypical parkinsonism and dementia syndromes.

    M.C. Peralta, M. Tourreilles, D. Menna, P. Perez Leguizamon, F. Taragano, M. Bastianello (Buenos Aires, Argentina)

    Objective: To describe the fluorodeoxyglucose (FDG) metabolic pattern and clinical features in patients with clinical diagnose of atypical parkinsonism such as Progressive Supranuclear Palsy (PSP),…
  • 2017 International Congress

    The Relative Preservation of the Dopaminergic Neuroal Loss of Patients with Parkinson’s Disease Having Dopamine-Unresponsive Resting Tremor

    S. You, H.W. Kim (Daegu, Republic of Korea)

    Objective: To investigate the difference of dopaminergic neuronal loss between PD patients with dopamine-unresponsive and -responsive resting tremor. Background: Resting tremor (RT) is one of…
  • 2017 International Congress

    18F-labeled FP-CIT PET Findings in a series of cirrhotic patients with parkinsonism

    H.-J. Yang, S.H. Park, Y. Kim (Ulsan, Republic of Korea)

    Objective: Our object is to evaluate the cirrhotic patients with parkinsonism using the presynaptic dopamine transporter (DAT) positron emission tomography (PET) imaging for dopaminergic deficit.…
  • 2016 International Congress

    Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers

    H. Wilson, F. Niccolini, S. Haider, T. Reis Marques, G. Pagano, C. Coello, S. Natesan, S. Kapur, E.A. Rabiner, R.N. Gunn, S.J. Tabrizi, M. Politis (London, United Kingdom)

    Objective: Using positron emission tomography (PET) with [11C]IMA107, we investigated the in vivo expression of PDE10A in extra-striatal regions in a cohort of 12 early…
  • 2016 International Congress

    Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

    M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To measure the expression of the Parkinson's disease related cognitive pattern (PDCP) in 18F-FDG-PET brain images of Parkinson's disease (PD) patients and healthy controls…
  • 2016 International Congress

    Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study

    I. Trender-Gerhard, E. Michou, A. Gerhard, D. Craufurd, S. Hamdy, K. Herholz (Manchester, United Kingdom)

    Objective: To assess the central neural control of swallowing in HD patients with mild dysphagia using a multimodal imaging approach combining qualitative and quantitative swallowing…
  • 2016 International Congress

    The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

    S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)

    Objective: The objective of this study was to identify metabolic group differences between Idiopatic Parkinson's disease patients with dementia (PDD) and without dementia (PD), by…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley